Analysis of Liver Injury Risk Factors in a Multiethnic Population Treated With Antituberculosis Drugs

Active, not recruitingOBSERVATIONAL

Enrollment

127

Participants

Timeline

Start Date

July 5, 2024

Primary Completion Date

July 30, 2024

Study Completion Date

September 30, 2024

Conditions

Tuberculosis Infection

Interventions

DRUG

standard anti-TB treatment

standard anti-TB treatment in line with international guidelines (isoniazid , rifampin, ethambutol, and pyrazinamide)

Trial Locations (1)

ASST Fatebenefratelli Sacco, Milan

All Listed Sponsors

lead

Stefania Cheli

OTHER